Do like the potential here. FDA catalyst soon, pot
Post# of 405
Posted On: 05/26/2016 6:16:58 AM
Do like the potential here. FDA catalyst soon, potential approval for fluticare. Expanding revs and looking good into 2017. No R/S for uplisting and no immediate hurry to uplist. CEO Dr. Damaj says they want $3 for uplisting, if things progress well they won't need to RS, if they do by then it would be minimal. His track record says they won't need it.
(0)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼